We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+19.44%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.38B
AUM Growth
-$27.3M
Cap. Flow
-$219M
Cap. Flow %
-9.21%
Top 10 Hldgs %
39.28%
Holding
114
New
41
Increased
19
Reduced
15
Closed
25

Top Buys

Rank Stock Value
1
BHVN icon
Biohaven
BHVN
+$53.5M
2
T icon
AT&T
T
+$52.8M
3
NKE icon
Nike
NKE
+$50.1M
4
WYNN icon
Wynn Resorts
WYNN
+$50.1M
5
FIS icon
Fidelity National Information Services
FIS
+$49.2M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$89.1M
2
DIS icon
Walt Disney
DIS
+$87.4M
3
AMZN icon
Amazon
AMZN
+$82.9M
4
IQV icon
IQVIA
IQV
+$71.9M
5
GPN icon
Global Payments
GPN
+$71.2M

Sector Composition

Rank Sector Weight
1 Healthcare 46.26%
2 Consumer Discretionary 16.29%
3 Industrials 12.13%
4 Consumer Staples 8.08%
5 Technology 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
1
UnitedHealth
UNH
$382B
$136M 5.72%
256,714
+15,717
+7% +$8.33M
UNP icon
2
Union Pacific
UNP
$183B
$108M 4.53%
521,173
-11,932
-2% -$2.45M
OTIS icon
3
Otis Worldwide
OTIS
$27.4B
$102M 4.27%
1,297,480
– –
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$99.5M 4.18%
874,291
+161,730
+23% +$13.4M
EL icon
5
Estee Lauder
EL
$29B
$98.9M 4.15%
398,506
+28,923
+8% +$6.46M
TPR icon
6
Tapestry
TPR
$28.8B
$83M 3.49%
2,180,922
– –
KURA icon
7
Kura Oncology
KURA
$922M
$79.1M 3.32%
6,376,815
+2,313,687
+57% +$33.6M
LVS icon
8
Las Vegas Sands
LVS
$30.5B
$78.1M 3.28%
1,625,685
-768,266
-32% -$32.6M
RPRX icon
9
Royalty Pharma
RPRX
$26.1B
$78M 3.28%
1,974,625
+131,907
+7% +$5.51M
ACLX
10
DELISTED
Arcellx
ACLX
$72.8M 3.06%
2,350,333
+100,800
+4% +$2.31M
NKE icon
11
Nike
NKE
$61.9B
$58.3M 2.45%
+497,937
New +$50.1M
CP icon
12
Canadian Pacific Kansas City
CP
$82B
$57.1M 2.4%
765,840
-10,436
-1% -$785K
WYNN icon
13
Wynn Resorts
WYNN
$10.1B
$56.5M 2.37%
+685,001
New +$50.1M
HLT icon
14
Hilton Worldwide
HLT
$74B
$55.2M 2.32%
436,756
-108,415
-20% -$14.3M
ITCI
15
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$54.9M 2.3%
1,036,948
+184,990
+22% +$9.27M
T icon
16
AT&T
T
$165B
$54.3M 2.28%
+2,951,900
New +$52.8M
BHVN icon
17
Biohaven
BHVN
$2.16B
$53.4M 2.24%
3,848,938
+3,785,889
+6,005% +$53.5M
XYZ
18
Block Inc
XYZ
$45.9B
$53.1M 2.23%
844,303
+182,763
+28% +$11.3M
CL icon
19
Colgate-Palmolive
CL
$72.6B
$50.8M 2.13%
+644,580
New +$48.3M
INSM icon
20
Insmed
INSM
$23.2B
$50.4M 2.12%
2,520,901
+1,290,101
+105% +$24.9M
SCHW
21
Charles Schwab
SCHW
$177B
$50.3M 2.11%
+604,204
New +$46.9M
FIS icon
22
Fidelity National Information Services
FIS
$21.5B
$47M 1.97%
+693,005
New +$49.2M
STRO icon
23
Sutro Biopharma
STRO
$379M
$45M 1.89%
556,510
+54,510
+11% +$3.79M
SBUX icon
24
Starbucks
SBUX
$118B
$44.4M 1.87%
+448,041
New +$42.3M
DG icon
25
Dollar General
DG
$25.9B
$42.8M 1.8%
+173,850
New +$43M
1
2 3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return

Suvretta Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Suvretta Capital Management held 114 positions worth $2.38B, down 1.1% from $2.41B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Suvretta Capital Management withdrew a net $219M in Q4 2022, closing 25 positions and reducing 15 holdings. Its most notable exit was Microsoft, an estimated $89.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 45% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Suvretta Capital Management opened a new position in AT&T worth $54.3M.

  • Suvretta Capital Management's largest Q4 2022 buy was AT&T: 2,951,900 shares worth $54.3M.
  • Suvretta Capital Management added most to Biohaven in Q4 2022, an estimated $53.5M increase.
  • Suvretta Capital Management's biggest Q4 2022 reduction was IQVIA, cutting an estimated $71.9M.
  • Suvretta Capital Management fully exited Microsoft in Q4 2022, selling an estimated $89.1M.
  • Suvretta Capital Management's ten largest holdings make up 39% of its $2.38B portfolio in Q4 2022.
  • Suvretta Capital Management opened 41 new positions and closed 25 in Q4 2022.
  • Suvretta Capital Management's portfolio value fell 1.1% quarter-over-quarter to $2.38B.

Based on Suvretta Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.